GRK2 Gene

Name G protein-coupled receptor kinase 2
Description This gene encodes a member of the G protein-coupled receptor kinase family of proteins. The encoded protein phosphorylates the beta-adrenergic receptor as well as a wide range of other substrates including non-GPCR cell surface receptors, and cytoskeletal, mitochondrial, and transcription factor proteins. Data from rodent models supports a role for this gene in embryonic development, heart function and metabolism. Elevated expression of this gene has been observed in human patients with heart failure and Alzheimer's disease. [provided by RefSeq, Sep 2017]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n G protein‐coupled receptor kinase 2 (GRK2) is emerging as a multifunctional regulator of receptor signaling, acting not only in the classical phosphorylation‐dependent desensitization of activated G protein–coupled receptors (GPCRs) but also as a nexus that connects receptors to diverse downstream effectors. Upon agonist stimulation of receptors such as the β2‐adrenergic, CXCR4, S1P1, Smoothened, and FSH receptors, GRK2 phosphorylates activated receptors to promote β‐arrestin recruitment, which initiates receptor uncoupling, internalization, and even alternative signaling pathways (see, for example."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": " In many cases, however, GRK2’s enzymatic activity is tightly regulated by its own subcellular localization, which depends on its translocation to the plasma membrane via Gβγ binding, and by post‐translational modifications such as S‐nitrosylation that modulate its catalytic efficiency."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its canonical role in receptor desensitization, GRK2 can directly phosphorylate non‐receptor substrates including proteins involved in cytoskeletal organization – for instance, it phosphorylates ezrin to couple receptor activation to actin reorganization"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", and it influences the “barcode” of receptor phosphorylation that dictates β‐arrestin conformations and subsequent signaling outcomes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " GRK2 also participates in the regulation of receptor stability; its activity is required for ligand‐induced degradation of receptors such as the S1P1, and it orchestrates the removal of ciliary GPCRs by facilitating β‐arrestin binding."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In pathophysiological contexts, aberrant GRK2 expression or activity has been implicated in several disorders. In the heart, elevated GRK2 disrupts β‐adrenergic receptor signaling and contributes to maladaptive remodeling and metabolic disturbances by phosphorylating substrates such as the insulin receptor substrate‐1, thereby impairing glucose uptake."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " In addition, increased GRK2 levels in immune cells during sepsis are associated with impaired chemotaxis and reduced receptor responsiveness."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "14"}]}, {"type": "t", "text": " Moreover, GRK2 interactions with regulatory partners such as spinophilin"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "and FMRP"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": "further modulate its impact on receptor signaling. Finally, GRK2 protein turnover is controlled via Mdm2‐mediated ubiquitination"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": ", reflecting a broader network of regulation that allows fine tuning of its cellular levels.\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies highlight GRK2 as a central, multifaceted modulator of GPCR function that not only terminates receptor signaling via desensitization and internalization but also bridges receptor activation to broader cellular responses. By regulating both receptor fate and engaging in cross‐talk with non‐receptor targets, GRK2 represents a key node in the maintenance of cellular homeostasis and is implicated in the pathogenesis of cardiovascular, metabolic, inflammatory, and neurological disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "18"}, {"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "20"}, {"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "21"}, {"type": "fg_f", "ref": "16"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_f", "ref": "23"}, {"type": "fg_f", "ref": "13"}, {"type": "fg_f", "ref": "24"}, {"type": "fg_f", "ref": "15"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "25"}, {"type": "fg_f", "ref": "17"}, {"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sudha K Shenoy, Matthew T Drake, Christopher D Nelson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M506576200"}], "href": "https://doi.org/10.1074/jbc.M506576200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16280323"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16280323"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kelly N Nobles, Kunhong Xiao, Seungkirl Ahn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2001707"}], "href": "https://doi.org/10.1126/scisignal.2001707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21868357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21868357"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Cornelius Krasel, Moritz Bünemann, Kristina Lorenz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413078200"}], "href": "https://doi.org/10.1074/jbc.M413078200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15634674"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15634674"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Erin J Whalen, Matthew W Foster, Akio Matsumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2007.02.046"}], "href": "https://doi.org/10.1016/j.cell.2007.02.046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17482545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17482545"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kristina Lorenz, Martin J Lohse, Ursula Quitterer "}, {"type": "b", "children": [{"type": "t", "text": "Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature02158"}], "href": "https://doi.org/10.1038/nature02158"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14654844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14654844"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Sarah H Cant, Julie A Pitcher "}, {"type": "b", "children": [{"type": "t", "text": "G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e04-10-0877"}], "href": "https://doi.org/10.1091/mbc.e04-10-0877"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15843435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15843435"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Fan Yang, Xiao Yu, Chuan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and (19)F-NMR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9202"}], "href": "https://doi.org/10.1038/ncomms9202"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26347956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26347956"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Myat Lin Oo, Shobha Thangada, Ming-Tao Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M610318200"}], "href": "https://doi.org/10.1074/jbc.M610318200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17237497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17237497"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kasturi Pal, Sun-Hee Hwang, Bandarigoda Somatilaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smoothened determines β-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201506132"}], "href": "https://doi.org/10.1083/jcb.201506132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27002170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27002170"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Michele Ciccarelli, J Kurt Chuprun, Giuseppe Rengo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.110.988642"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.110.988642"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21518983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21518983"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Philip W Raake, Leif E Vinge, Erhe Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.107.168336"}], "href": "https://doi.org/10.1161/CIRCRESAHA.107.168336"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18635825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18635825"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jose C Alves-Filho, Andressa Freitas, Fabricio O Souto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0900196106"}], "href": "https://doi.org/10.1073/pnas.0900196106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19234125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19234125"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Peishen Zhao, TinaMarie Lieu, Nicholas Barlow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.642736"}], "href": "https://doi.org/10.1074/jbc.M115.642736"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25878251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25878251"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Hanneke L D M Willemen, Xiao-Jiao Huo, Qi-Liang Mao-Ying, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-124 as a novel treatment for persistent hyperalgesia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroinflammation (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1742-2094-9-143"}], "href": "https://doi.org/10.1186/1742-2094-9-143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22731384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22731384"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Qin Wang, Jiali Zhao, Ashley E Brady, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1098274"}], "href": "https://doi.org/10.1126/science.1098274"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15218143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15218143"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Hansen Wang, Long-Jun Wu, Susan S Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FMRP acts as a key messenger for dopamine modulation in the forebrain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuron (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuron.2008.06.027"}], "href": "https://doi.org/10.1016/j.neuron.2008.06.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18760699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18760699"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Alicia Salcedo, Federico Mayor, Petronila Penela "}, {"type": "b", "children": [{"type": "t", "text": "Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7601351"}], "href": "https://doi.org/10.1038/sj.emboj.7601351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17006543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17006543"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Wei Chen, Xiu-Rong Ren, Christopher D Nelson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1104135"}], "href": "https://doi.org/10.1126/science.1104135"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15618519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15618519"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "John M Busillo, Sylvain Armando, Rajarshi Sengupta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.091173"}], "href": "https://doi.org/10.1074/jbc.M109.091173"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20048153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20048153"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Anastasios Lymperopoulos, Giuseppe Rengo, Hajime Funakoshi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1553"}], "href": "https://doi.org/10.1038/nm1553"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17322894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17322894"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xiaowen Liu, Bo Ma, Asrar B Malik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni.2258"}], "href": "https://doi.org/10.1038/ni.2258"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22447027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22447027"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Tal I Arnon, Ying Xu, Charles Lo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1208248"}], "href": "https://doi.org/10.1126/science.1208248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21960637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21960637"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Sébastien Marion, David M Weiner, Marc G Caron "}, {"type": "b", "children": [{"type": "t", "text": "RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M308742200"}], "href": "https://doi.org/10.1074/jbc.M308742200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14602721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14602721"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Rongxuan Zhu, Olivier Gires, Liqun Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-10739-3"}], "href": "https://doi.org/10.1038/s41467-019-10739-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31253779"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31253779"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Elodie Kara, Pascale Crépieux, Christophe Gauthier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2006-0098"}], "href": "https://doi.org/10.1210/me.2006-0098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16887887"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16887887"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "R T Premont, A Claing, N Vitale, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2000)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.275.29.22373"}], "href": "https://doi.org/10.1074/jbc.275.29.22373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "10896954"}], "href": "https://pubmed.ncbi.nlm.nih.gov/10896954"}]}]}]}
NCBI Gene ID 156
API
Download Associations
Predicted Functions View GRK2's ARCHS4 Predicted Functions.
Co-expressed Genes View GRK2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View GRK2's ARCHS4 Predicted Functions.

Functional Associations

GRK2 has 3,461 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 45 datasets.

Click the + buttons to view associations for GRK2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of GRK2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of GRK2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Proteomics Cell lines associated with GRK2 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with GRK2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of GRK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of GRK2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing GRK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing GRK2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with GRK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by GRK2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DGIdb Drug Targets 2026 interacting drugs for GRK2 protein from the DGIdb Drug Targets 2026 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with GRK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with GRK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with GRK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with GRK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GO Biological Process Annotations 2023 biological processes involving GRK2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving GRK2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2023 cellular components containing GRK2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing GRK2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by GRK2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by GRK2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of GRK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with GRK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of GRK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of GRK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving GRK2 protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of GRK2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of GRK2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by GRK2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of GRK2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PFOCR Pathway Figure Associations 2023 pathways involving GRK2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving GRK2 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving GRK2 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of GRK2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of GRK2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of GRK2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of GRK2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of GRK2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of GRK2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with GRK2 gene from the SynGO Synaptic Gene Annotations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of GRK2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of GRK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of GRK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with GRK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving GRK2 protein from the WikiPathways Pathways 2024 dataset.